Señales en vivo de CELC | Maximiza tus Ganancias con Getagraph.com

COMPRAR 120908 min ago

@ $15.21

Emitido: 13 feb 2024 @ 09:42

Retorno: 17.62%

Señal anterior: feb 9 - 09:30

Señal anterior: Vender

Retorno: 3.75 %

Live Chart Being Loaded With Signals

Commentary (7 may 2024 @ 09:48):

Celcuity Inc., a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States...

Stats
Volumen de hoy	34 336.00
Volumen promedio	242 109
Capitalización de mercado	544.81M
EPS	$0 ( 2024-03-27 )
Próxima fecha de ganancias	( $0 ) 2024-05-13
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-6.65
ATR14	$0.0380 (0.21%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-26	Sullivan Brian F.	Sell	45 025	Common Stock
2024-04-26	Sullivan Brian F.	Buy	45 025	Common Stock
2024-04-24	Buller Richard E	Sell	350	Common Stock
2024-04-08	Buller Richard E	Buy	19 558	Stock Option (right to buy)
2024-04-08	Buller Richard E	Buy	12 654	Stock Option (right to buy)

INSIDER POWER
8.70
Last 100 transactions
Buy: 4 121 398 \| Sell: 3 000 264

Volumen Correlación

Largo: 0.26 (neutral)

Corto: 0.87 (strong)

Signal:(68.829) Same movement expected

Celcuity Inc Correlación

10 Correlaciones Más Positivas
NICE	0.919
LNW	0.91
NOTV	0.906
CROX	0.904
DVOL	0.895
PCAR	0.895
BRKR	0.895
CPRT	0.894
DAX	0.892
EBIZ	0.892

10 Correlaciones Más Negativas
NH	-0.872
IRDM	-0.846
VORB	-0.841
DCRC	-0.841
PEAR	-0.84
DPRO	-0.84
LAWS	-0.836
SABR	-0.835
TCFC	-0.834
PYR	-0.834

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Celcuity Inc Correlación - Moneda/Commodity

-0.21
( neutral )

-0.27
( neutral )

0.00
( neutral )

0.41
( neutral )

0.52
( weak )

0.48
( neutral )

Celcuity Inc Finanzas

Annual	2023
Ingresos:	$0
Beneficio Bruto:	$-142 772 (0.00 %)
EPS:	$-2.69

FY	2023
Ingresos:	$0
Beneficio Bruto:	$-142 772 (0.00 %)
EPS:	$-2.69

FY	2022
Ingresos:	$0
Beneficio Bruto:	$-210 918 (0.00 %)
EPS:	$-2.68

FY	2021
Ingresos:	$0.00
Beneficio Bruto:	$0.00 (0.00 %)
EPS:	$-2.88

Financial Reports:

No articles found.

Celcuity Inc

Celcuity Inc., a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therapy for the treatment. Its drug candidate includes Gedatolisib, which selectively targets various class I isoforms of PI3K and mammalian target of rapamycin and focus on the treatment of patients with hormone receptor positive, HER2-negative, and advanced or metastatic breast cancer. The company is also developing CELsignia MP test, a qualitative laboratory developed test that measures HER2, c-Met, and PI3K signaling activity in breast and ovarian tumor cells. It had a license agreement with Pfizer, Inc. for the development and commercialization rights to Gedatolisib. Celcuity Inc. was founded in 2011 and is headquartered in Minneapolis, Minnesota.